PMCB CIK: 1157075

PharmaCyte Biotech, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
Change from FY22 to FY26
millions USD
FY22:
−4.12
FY23:
−3.79
FY24:
−2.15
FY25:
−2.98
FY26:
−5.15
millions USD
FY22:
0
FY23:
0
FY24:
−5.00
FY25:
−7.00
FY26:
2.00
Change from FY22 to FY26
millions USD
FY22:
87.3
FY23:
−13.6
FY24:
−10.7
FY25:
−25.0
FY26:
6.58
millions USD
FY22:
83.2
FY23:
−17.4
FY24:
−17.9
FY25:
−35.0
FY26:
3.43
(positive)
millions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
−2.98
FY26:
–

All amounts in millions USD Data sources:SEC EDGARTwelve Data